RIL
GYRE icon

Rothschild Investment LLC’s Gyre Therapeutics GYRE Stock Holding History

Rothschild Investment LLC’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7 Buy
+1
New +$7 ﹤0.01% 3625

Other funds holding GYRE

SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Rothschild Investment LLC's GYRE Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Gyre Therapeutics (GYRE) in Q2 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3625 among its holdings.

18 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Rothschild Investment LLC held 1 share of Gyre Therapeutics worth $7 as of Q2 2026.
  • Gyre Therapeutics was a new Rothschild Investment LLC position in Q2 2026.
  • Gyre Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3625 holding.
  • 18 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.